Skip to main content
OpenTrials
Completed

NCT Number: NCT01512641

Prevalence of Dissociative Disorders in Children

Schizophrenia beginning before 18 years is a clinical entity not well known because of its low incidence and difficulties in the clinical diagnosis.

However, in the investigators clinical practice, due to the specialization of the investigators service, the investigators are led to hospital to receive important feel active of patients meeting the Diagnostic and Statistical Manual of Mental Disorders IV text revision (DSM IV-TR) precose schizophrenia.

The work of us team on the theme of the relationship between Pervasive Developmental Disorders and precose Schizophrenia led us to hypothesize that a number of children in care in the medical and educational institutes, hospitals and day shelters therapeutic part-time symptoms of schizophrenia or a line real early diagnosis of schizophrenia undervalued or not diagnosed.

The main goal is to estimate the prevalence of dissociative disorders in a population of children in care institutions and medical education in child psychiatry in hospitals and others structures.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dissociative Disorders Mental Disorders Schizophrenia Schizophrenia Spectrum and Other Psychotic Disorders

Age range

7 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Psychiatrie infanto-juvénile - Centre Hospitalier d'Antibes, Antibes, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 7 to 18 years
  • Supported in the partner institutions of the study
  • IQ>35 on the certificate of orientation of the Maison Départementale des Personnes Handicapées (MDPH)
  • Obtaining the agreement of parents and children

Exclusion criteria

  • QI<35 on the certificate file Guidance MDPH
  • Children not speaking french

Treatment and study plan

Primary stage

Other

Kiddie-Schedule for Affective Disorders and Schizophrenia

Secondary stage

Other

children who are positive to the kiddie-SADS (primary stage), will take the tests: PANSS, Scale for the Assessment of Negative Symptoms (SANS), ADI-R, scale TLC and WISC IV

Primary outcomes

  1. Rate of children diagnosed with dissociative disorders

    Time frame: between 2 and 4 hours depending children

    Rate of children diagnosed with dissociative disorders: children positive for the test Kiddie-Schedule for Affective Disorders and Schizophrenia (Kiddie-SADS).

Secondary outcomes

  1. Percentage of children positive for test: Autism Diagnostic Interview-Revise (ADI-R).

    Time frame: 1 day on average

  2. Scores of three dimensions of schizophrenia in the Positive And Negative Syndrome Scale (PANSS)

    Time frame: 4 hours

    3 dimensions: positive symptoms, negative symptoms and general psychopathology, based on these scores the diagnostic subtype of schizophrenia is established.

  3. Score at the Test Lillois de Communication (TLC)

    Time frame: 30 minutes

  4. Score on the Wechsler Intelligence Scale for Children-Fourth Edition (WISC IV)subtests and overall intelligence quotient (IQ).

    Time frame: 4 hours

  5. Response time to test verbal fluency, scores on the Trail Making Test A (TMT) and TMT B.

    Time frame: 30 minutes

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nice

Other

Registry information

Official study title

Prevalence of Dissociative Disorders in Children in a Population Supported in the Medico-social and Health Structures in Provence Alpes Cote d'Azur

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
Jan 19, 2012
Registry last updated
Feb 3, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.